t
| TIDM | IBT |
| Share Price | 1,083.47p-1.83% |
| Market Cap | £448.38m |
On 02 October 2026, International Biotechnology Trust PLC announced it is satisfied that all inside information for the period leading up to its annual results for the year ended 31 August 2026 has been, and will continue to be, notified via a regulatory information service, meaning the Company is not prohibited from dealing in its own securities. The Company has provided Deutsche Numis with a non-discretionary dealing instruction for share buybacks, and the mandatory closed period under MAR will last until the results for the year ended 31 August 2026 are published, expected on or around 03 November 2026.
| Date | 2 Oct 2026 |
| Time | 17:28:31 |
| Category | Miscellaneous |
| ID | 4908X |
2 October 2026
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
(the "Company")
Compliance with Market Abuse Regulation (MAR)
The Company announces that it is satisfied that all inside information which the Directors and the Company may have in the period leading up to the announcement of its annual results for the year ended 31 August 2026 has previously been, and will continue to be, notified via a regulatory information service (RIS). Therefore, the Company is not prohibited from dealing in its own securities.
The mandatory closed period under MAR will last until the results in respect of the year ended 31 August 2026 are published, expected to be on or around 3 November 2026.
The Company has provided Deutsche Numis, its corporate broker, with a non-discretionary dealing instruction under which it may undertake share buybacks if, in the period leading up to the announcement of the annual results, the Directors of the Company come into the possession of any inside information.
Enquiries:
Schroder Investment Management Limited
Michelle Taiwo
Tel: 0207 658 6000